NCT00544869View on ClinicalTrials.gov

A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Cardiac Edema
Interventions
DRUG

OPC-41061 （Tolvaptan)

15-30mg/day,daily for 14days

Trial Locations (6)

Unknown

Chubu Region

Hokkaido Region

Kanto Region

Kinki Region

Kyuush

Shikoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY